Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
Glanzmann’s Research Foundation shared a post on LinkedIn:
“More than four years ago, we visited David Wilcox and his team at the Medical College of Wisconsin, where they have spent decades advancing a potential gene therapy cure for GlanzmannThrombasthenia.
Today, we are closer than ever to clinical trials, and we’ll soon be returning to the lab to see firsthand how much progress has been made.
The science is there. The expertise is there.
The biggest barrier to this research reaching patients is funding.
What makes the us so unique as a non-profit in the rare bleeding disorders space is that all donations directly support research to find a cure.
Every donation helps move this promising therapy one step closer to clinical trials.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL
-
Nov 12, 2026, 22:44Mary Cushman: New Position at the Vermont Center for Cardiovascular and Brain Health
-
Nov 12, 2026, 22:43Lama Alstanbuli: Discussing and Optimizing Stroke Pathways Across Healthcare Systems